Physician profile
Mitchell E Myers
NPI 1508398918
$3,457.49
in general payments reported to CMS, 2019-2025
15 companies · $47.41 in 2025
The $47.41 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $2,619 · 2023: $362 · 2024: $235 · 2025: $47.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,629.69 | 2022-2024 | Mako, Triathlon, Accolade |
| Pylant Medical | $1,200.00 | 2022 | |
| Vericel Corporation | $145.11 | 2021 | |
| Medtronic, INC. | $117.39 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $64.76 | 2021-2024 | Exparel, Iovera, Zilretta |
| Depuy Synthes Sales INC. | $64.29 | 2022-2023 | Fibulink |
| Boston Scientific Corporation | $41.36 | 2024 | Advantage System |
| Novo Nordisk INC | $37.70 | 2023 | Ozempic, Rybelsus |
| Biocomposites INC | $29.44 | 2024 | |
| Midsouth Orthopedics INC. | $25.93 | 2021 | |
| Mission Medical Distribution, LLC | $25.80 | 2025 | |
| Kerecis Limited | $21.61 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Vertex Pharmaceuticals Incorporated | $19.53 | 2024 | |
| Zimmer Biomet Holdings, INC. | $17.62 | 2022 | |
| Bioventus LLC | $17.26 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Myers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.